Sie suchten nach: rheumatologic (Englisch - Maltesisch)

similar rates were shown across rheumatologic indications.
rati simili intwerew fost l-indikazzjonijiet rewmatoloġiċi.

study iv evaluated 1,220 patients who had an inadequate response to their existing rheumatologic therapy, including one or more dmards.
studju iv ivvaluta 1,220 pazjent li kellhom rispons mhux adegwat għat-terapija rewmatoloġika li kienu qed jieħdu, inkluż dmard wieħed jew aktar.

anti-rheumatic drug-naïve or to remain on their pre-existing rheumatologic therapy provided that therapy was stable for a minimum of 28 days.
il- pazjenti kienujew ma jafux li qegħdin jieħdu mediċina anti- rewmatika li taffetwa l- proċess tal- mard, jew tħallew ikomplu jieħdu t- terapija anti- rewmatoloġika li kienu diġà qegħdin jieħdu, u dan sakemm il- kura kienet stabbli għall- perjodu minimu ta ’ 28 ġurnata.

in patients with rheumatoid arthritis celecoxib had no statistically significant effect on the pharmacokinetics (plasma or renal clearance) of methotrexate (in rheumatologic doses).
f’pazjenti bl-artrite rewmatika, celecoxib ma kellu ebda effett statistiku sinifikanti fuq il- farmakokinetiċi (tneħħija mill-plażma jew renali) ta’ methotrexate (f’dożi rewmatoloġiċi).

patients were permitted to be either disease-modifying, anti-rheumatic drug-naïve or to remain on their pre-existing rheumatologic therapy provided that therapy was stable for a minimum of 28 days.
il-pazjenti kienujew ma jafux li qegħdin jieħdu mediċina anti-rewmatika li taffetwa l-proċess tal-mard , jew tħallew ikomplu jieħdu t-terapija anti-rewmatoloġika li kienu diġà qegħdin jieħdu, u dan sakemm il-kura kienet stabbli għall-perjodu minimu ta’ 28 ġurnata.